tradingkey.logo
tradingkey.logo

Sarepta Announces That Screening And Enrollment Are Underway In Endeavor Cohort 8 To Evaluate Enhanced Immunosuppression Regimen As Part Of Elevidys Gene Therapy For Non-Ambulant Individuals With Duchenne

ReutersMar 16, 2026 12:39 PM

- Sarepta Therapeutics Inc SRPT.O:

  • SAREPTA ANNOUNCES THAT SCREENING AND ENROLLMENT ARE UNDERWAY IN ENDEAVOR COHORT 8 TO EVALUATE ENHANCED IMMUNOSUPPRESSION REGIMEN AS PART OF ELEVIDYS GENE THERAPY FOR NON-AMBULANT INDIVIDUALS WITH DUCHENNE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI